Biventricular Pacing in Congenital Heart Disease: Technical Challenges
Cardiac resynchronization therapy (CRT) can improve ventricular coordination in selected patients with congenital heart disease (CHD), yet the procedure rarely follows the standard pathway used in acquired cardiomyopathy. Abnormal cardiac position, surgically altered venous anatomy, intracardiac shunts, systemic right ventricles, and extensive scar tissue can complicate every stage of implantation.
Biventricular pacing in congenital heart disease requires a detailed understanding of anatomy, previous operations, ventricular mechanics, and the limitations of available hardware. A technically successful implant may still provide little benefit if the lead does not capture the appropriate myocardial region or if pacing worsens atrioventricular or interventricular interaction.
The field therefore depends on individualized imaging, careful electrophysiological assessment, and long-term follow-up. Multidisciplinary planning involving congenital cardiology, electrophysiology, cardiac imaging, surgery, and anesthesia is often essential, particularly for patients with complex repairs or limited venous access.
Why Resynchronization Is Difficult
The usual CRT model assumes a dilated left ventricle, a reachable coronary sinus, and a predictable pattern of electrical delay. Those assumptions frequently fail in CHD. Patients may have a systemic right ventricle after atrial switch or arterial switch-related procedures, a single-ventricle circulation, a lateral tunnel or extracardiac conduit, or ventricular geometry that has been reshaped by surgery.
Electrical activation can also differ substantially from the surface electrocardiographic pattern. A wide QRS complex may reflect bundle branch block, surgical incision, ventricular hypertrophy, or diffuse conduction disease. Similarly, a narrow QRS does not exclude meaningful mechanical dyssynchrony. Standard criteria developed for ischemic or nonischemic left ventricular failure should therefore be interpreted alongside imaging and congenital anatomy.
The therapeutic objective may be improved systemic ventricular function, reduced filling pressures, better exercise capacity, or stabilization before further deterioration. In some patients, CRT is considered during an upgrade from chronic right ventricular pacing, especially when pacing-induced dysfunction is suspected. In others, the main challenge is identifying whether dyssynchrony is a modifiable contributor to heart failure at all.
Anatomy And Previous Operations
Venous anatomy is often the first obstacle. Persistent left superior vena cava, interrupted inferior vena cava, azygos continuation, bilateral superior vena cavae, venous occlusion, and surgically created pathways can make transvenous lead delivery difficult or impossible. A preprocedural computed tomography scan, magnetic resonance study, venogram, or detailed review of operative records can prevent unexpected findings in the laboratory.
The position of the heart may be dextrocardic, mesocardiac, or associated with heterotaxy. The coronary sinus can have an unusual orientation, and its branches may be small, angulated, stenotic, or absent in the region needed for effective resynchronization. In patients with a Fontan circulation, transvenous access may be restricted by the circulation itself, and systemic embolic risk must be considered when intracardiac leads are contemplated.
Prior sternotomy and congenital repair also alter the risk profile of epicardial implantation. Adhesions can make surgical exposure demanding, while diaphragmatic or lateral ventricular surfaces may be difficult to reach. Surgical scars may create electrically inert regions, meaning that a visually convenient epicardial site is not necessarily a physiologically useful one.
Finding An Effective Ventricular Target
Lead placement should be guided by the region of latest electrical or mechanical activation, provided that the site is viable and accessible. Echocardiography can identify contraction patterns, dyssynchrony, ventricular strain, and scar-related abnormalities. Cardiac magnetic resonance imaging may add information about fibrosis and ventricular volumes, although device compatibility, renal function, and prior surgical materials can affect its use.
For a systemic left ventricle, a lateral or posterolateral coronary venous branch may remain a reasonable target. However, the best site is determined by anatomy and activation rather than by a fixed fluoroscopic position. In a systemic right ventricle, the anatomical assumptions are different, and coronary sinus pacing may not engage the region that most effectively improves systemic ventricular contraction.
Conduction system pacing, including His-bundle pacing and left bundle branch area pacing, has become an important alternative in selected patients. These methods may restore more physiological activation and avoid some coronary sinus limitations, but congenital anatomy can make septal lead positioning unpredictable. Thickened myocardium, surgical patches, distorted septal landmarks, and unusual conduction pathways may increase threshold or reduce the likelihood of durable capture.
Delivery Strategies And Hardware
A transvenous approach is attractive because it avoids thoracotomy, but it depends on reliable venous access and a usable coronary sinus. Specialized sheaths, guidewires, telescoping catheters, and pre-shaped delivery systems may help negotiate tortuous anatomy. Venoplasty or lead extraction may be considered in carefully selected cases, although the risks can be substantial in young patients with long expected device exposure.
When a coronary sinus lead cannot be placed or produces unacceptable thresholds, an epicardial lead may be implanted surgically or robotically. Epicardial pacing allows direct access to the systemic ventricle and can be valuable in children, patients with Fontan physiology, and those with occluded veins. Its limitations include higher pacing thresholds, potential lead failure, generator revisions, and the cumulative burden of repeated operations.
Hybrid strategies can combine a transvenous right-sided lead with an epicardial systemic ventricular lead. In some anatomies, a second ventricular lead or multipoint pacing may broaden the available activation pattern. These approaches increase hardware complexity, so the expected physiological benefit should be weighed against infection risk, battery longevity, lead interactions, and future extraction concerns.
Programming And Assessing Response
Device programming is particularly important when atrioventricular conduction, ventricular morphology, and pacing sites vary from patient to patient. The atrioventricular delay should support filling without allowing intrinsic conduction to undermine ventricular resynchronization. Interventricular timing may require repeated optimization because the ideal sequence can change with heart rate, loading conditions, and medical therapy.
Assessment should combine symptoms with objective measures. Echocardiographic ventricular volumes, systemic ventricular ejection fraction, strain, Doppler filling patterns, exercise testing, oxygen consumption, biomarker trends, and device-recorded pacing percentages can help determine response. A favorable change in one measure does not always predict improvement in another.
| Clinical issue | Why it matters in CHD | Useful planning or follow-up approach |
|---|---|---|
| Venous obstruction or anomalous return | Prevents standard lead delivery and may raise embolic or procedural risk | Review cross-sectional imaging, venography, and operative records before implantation |
| Systemic right ventricle | Changes activation patterns and the ideal pacing target | Use congenital imaging expertise and consider conduction system or epicardial options |
| Coronary sinus limitations | A suitable lateral branch may be absent, inaccessible, or electrically ineffective | Map venous anatomy and test multiple pacing sites when feasible |
| Surgical scar and patches | Can cause poor capture, high thresholds, or regional mechanical impairment | Integrate MRI, echocardiography, and intraoperative electrical assessment |
| Low effective pacing percentage | Reduces the chance of sustained resynchronization | Address atrial arrhythmias, programming, fusion, and lead stability |
| Uncertain clinical response | Symptoms may be influenced by residual lesions, valve disease, or pulmonary vascular factors | Use serial imaging, exercise data, rhythm review, and congenital hemodynamic assessment |
A nonresponder should not be classified solely by a lack of ejection fraction improvement. Persistent atrioventricular valve regurgitation, elevated pulmonary pressures, arrhythmia burden, inadequate biventricular pacing, or progressive systemic ventricular disease may explain the result. Device interrogation should be paired with a reassessment of the original diagnosis and pacing configuration.
Patient Selection And Long-Term Care
Candidates are usually considered after standard heart failure therapy, correction of residual hemodynamic lesions where possible, and evaluation of rhythm-related causes of dysfunction. Important variables include systemic ventricular morphology, ventricular size, QRS duration and pattern, pacing burden, atrioventricular valve function, oxygen saturation, exercise tolerance, and the presence of ventricular scar.
The timing of implantation is difficult in younger patients. Waiting may allow irreversible remodeling, while early implantation exposes the patient to more generator changes, lead revisions, venous obstruction, and infection risk over a longer lifetime. Growth can change lead tension and alter the relationship between a lead and the myocardium, requiring surveillance beyond routine device checks.
Patients with CHD also have distinctive arrhythmia risks. Atrial tachyarrhythmias can reduce effective CRT delivery, while ventricular arrhythmias may prompt combined defibrillator consideration. The choice between CRT-pacing and CRT-defibrillation should account for systemic ventricular function, scar, prior ventricular tachycardia, anticipated longevity, competing congenital risks, and the psychological and technical consequences of shocks.
Long-term management should include periodic review of lead thresholds, battery performance, pacing percentage, arrhythmia episodes, ventricular function, and residual anatomical lesions. As technology evolves, the most appropriate strategy may shift from coronary sinus pacing to conduction system pacing, epicardial revision, or a hybrid configuration.
Building A Reliable Planning Pathway
A structured workflow can reduce avoidable complications and clarify the likely benefit before committing to an invasive procedure. Important practical priorities include:
- Reconstruct the congenital anatomy, operative history, venous pathways, and current hemodynamics before selecting a device route.
- Define the systemic ventricle and identify electrical or mechanical delay with imaging rather than relying on QRS duration alone.
- Compare transvenous, epicardial, conduction system, and hybrid strategies according to access, scar, growth, lead longevity, and future procedures.
- Test pacing thresholds and capture patterns at more than one plausible target when the anatomy permits.
- Establish objective follow-up measures before implantation so that response can be evaluated consistently over time.
Complex cases benefit from discussion in a specialist conference where imaging, electrophysiology, surgery, and congenital heart failure expertise are represented. Reviewing relevant themed research and educational material through the journal’s special issues can also help teams compare emerging approaches and recognize how quickly device strategies are changing.
Research Priorities And Clinical Translation
Evidence for CRT in CHD remains less extensive than evidence in conventional adult heart failure populations. Patient heterogeneity makes randomized trials difficult, and outcomes may be influenced by anatomy, age, prior operations, systemic ventricular morphology, and the timing of intervention. Prospective registries with standardized imaging, pacing-site descriptions, procedural endpoints, and long-term outcomes are needed.
Future studies should examine personalized activation mapping, leadless or wireless pacing concepts, adaptive CRT algorithms, and conduction system pacing in repaired congenital anatomy. Better tools for identifying myocardial scar and viable pacing targets may help distinguish patients who are likely to respond from those whose dysfunction is primarily hemodynamic or irreversible.
Clinical teams can strengthen the evidence base by reporting unsuccessful procedures, lead revisions, threshold changes, and patient-centered outcomes alongside ejection fraction. Authors preparing original research, technical reports, or reviews can consult the journal’s author information to align submissions with appropriate reporting and peer-review requirements.
Careful anatomical reconstruction, individualized pacing-site selection, and disciplined follow-up are central to effective resynchronization in congenital heart disease. Clinicians and investigators should continue sharing procedural experience and outcome data so that complex patients receive strategies grounded in both physiology and durable long-term care.